Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Decitabine in Treating Patients With Advanced Solid Tumors
This study has been completed.
Study NCT00030615 Information provided by National Cancer Institute (NCI)
First Received: February 14, 2002 Last Updated: January 10, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bladder Cancer
Breast Cancer
Melanoma (Skin)
Additional conditions recognized in this trial
Breast Neoplasms
Melanoma
Urinary Bladder Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Skin Diseases
Urinary Bladder Diseases
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
decitabine
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
USC/Norris Comprehensive Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
